Skip to main content
Log in

Sodium regulation of agonist and antagonist binding to β-adrenoceptors in intact and Ns-deficient membranes

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Agonist binding to various hormone receptors mediating adenylate cyclase inhibition is decreased by sodium ions. We studied the influence of Na+ on agonist and antagonist binding to β-adrenoceptors in membrane preparations of guinea pig lung, S49 lymphoma wild-type cells (WT) and their Ns-deficient cyc variants by measuring binding of the antagonist, [125I]iodocyanopindolol ([125I]CYP). At 37° C, sodium decreased the receptor affinity for the agonist, isoproterenol, in all three membrane preparations. In lung and WT membranes, Na+ steepened the shallow agonist competition curves in a manner similar to and synergistic with guanine nucleotides. When binding was performend at 4° C, sodium regulation but not guanine nucleotide regulation of agonist binding was preserved. At the low temperature, [125I]CYP affinity was reduced, and sodium increased [125I]CYP binding in both Ns-containing and Ns-deficient membranes by increasing the antagonist affinity without significant change in total receptor number. Compared to Na+, Li+ and K+ were much less potent and efficient in decreasing agonist and increasing antagonist binding. Na+ and Mg2+ had opposite effects on agonist binding in the Ns-containing lung and WT membranes but not in the Ns-deficient cyc membranes. The data indicate that sodium not only regulates binding of inhibitory hormone receptors but also agonist and antagonist binding to the adenylate cyclase stimulatory β-adrenoceptor. The finding that sodium regulation of β-adrenoceptor binding is also observed in the Ns α2 cyc membranes, furthermore, indicates that the target of sodium is not the α-subunit of Ns but possibly a component common to both types of receptor systems regulating adenylate cyclase activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aktories K, Hungerer KD, Robbel L, Jakobs KH (1984) Mechanisms and structural requirements of pertussis toxin action on adenylate cyclase. In: Abstract volume, 9th International Congress of Pharmacology. Macmillan Press, London, p 1655

    Google Scholar 

  • Briggs MM, Lefkowitz RJ (1980) Parallel modulation of catecholamine activation of adenylate cyclase and formation of the high-affinity agonist receptor complex in turkey erythrocyte membranes by temperature and cis-vaccenic acid. Biochemistry 19:4461–4466

    Google Scholar 

  • Brodde OE, Kuhlhoff F, Arroyo J, Prywarra A (1983) No evidence for temperature-dependent changes in the pharmacological specificity of β1- and β2-adrenoceptors in rabbit lung membranes. Nanyn-Schmiedeberg's Arch Pharmacol 322:20–28

    Google Scholar 

  • Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K 1)and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108

    Google Scholar 

  • Heidenreich KA, Weiland GA, Molinoff PB (1980) Characterization of radiolabeled agonist binding to β-adrenergic receptors in mammalian tissues. J Cyclic Nucleotide Res. 6:217–230

    Google Scholar 

  • Jakobs KH, Gehring U, Gaugler B, Pfeuffer T, Schultz G (1983) Occurrence of an inhibitory guanine nucleotide-binding regulatory component of the adenylate cyclase system in cyc variants of S49 lymphoma cells. Eur J Biochem 130:605–611

    Google Scholar 

  • Jakobs KH, Minuth M, Aktories K (1984) Sodium regulation of hormone-sensitive adenylate cyclase. J Recept Res 4:443–458

    Google Scholar 

  • Kleinstein J, Glossmann H (1978) Solubilisation of a mammalian β-adrenergic receptor. Naunyn-Schmiedeberg's Arch Pharmacol 305:191–200

    Google Scholar 

  • Limbird LE, Speck JL (1983) N-Ethylmaleimide, elevated temperature, and digitonin solubilization eliminate guanine nucleotide but not sodium effects on human platelet α2-adrenergic receptor-agonist interactions. J Cyclic Nucleotide Protein Phosphorylation Res 9:191–202

    Google Scholar 

  • Limbird LE, Speck JL, Smith SK (1982) Sodium ion modulates agonist and antagonist interactions with the human platelet alpha2-adrenergic receptor in membrane and solubilized preparations. Mol Pharmacol 21:609–617

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Manning DR, Gilman AG (1983) The regulatory components of adenylate cyclase and transducin. A family of structurally homologous guanine nucleotide-binding proteins. J Biol Chem 258:7079–7063

    Google Scholar 

  • Martin MW, Smith MM, Harden TK (1984) Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart. J Pharmacol Exp Ther 230:424–430

    Google Scholar 

  • Michel T, Hoffman BB, Lefkowitz RJ (1980) Differential regulation of the α2-adrenergic receptor by Na+ and guanine nucleotides. Nature 288:709–711

    Google Scholar 

  • Northup JK, Sternweis PC, Gilman AG (1983) The subunits of the stimulatory regulatory component of adenylate cyclase. Resolution, acitivity, and properties of the 35,000-dalton (β) subunit. J Biol Chem 258:11361–11368

    Google Scholar 

  • Pert CB, Snyder SH (1974) Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol Pharmacol 10:868–879

    Google Scholar 

  • Rosenberger LB, Yamamura HI, Roeske WR (1980) Cardiac muscarinic receptor binding is regulated by Na+ and guanyl nucleotides. J Biol Chem 255:820–823

    Google Scholar 

  • Ross EM, Maguire ME, Sturgill TW, Biltonen RL, Gilman AG (1977) Relationship between the β-adrenergic receptor and adenylate cyclase. Studies of ligand binding and enzyme activity in purified membranes of S49 lymphoma cells. J Biol Chem 252:5761–5775

    Google Scholar 

  • Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672

    Google Scholar 

  • Tsai BS, Lefkowitz RJ (1978) Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. Mol Pharmacol 14:540–548

    Google Scholar 

  • Ui M, Katada T, Murayama T, Kurose H, Yajima M, Tamura M, Nakamura T, Nogimori K (1984) Islet-activating protein, pertussis toxin: A specific uncoupler of receptor-mediated inhibition of adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:145–151

    Google Scholar 

  • U'Prichard DC, Bylund DB, Snyder SH (1978) (−)-(3H)-Epinephrine and (−)-(3H) dihydroalprenolol binding to β1- and β2-adrenergic receptors in brain, heart and lung membranes. J Biol Chem 253:5090–5102

    Google Scholar 

  • Weiland GA, Minneman KP, Molinoff PB (1979) Fundamental difference between the molecular interactions of agonist and antagonist with the β-adrenergic receptor. Nature 281:114–117

    Google Scholar 

  • Weiland GA, Minneman KP, Molinoff PB (1980) Thermodynamics of agonist and antagonist interactions with mammalian β-adrenergic receptors. Mol Pharmacol 18:341–347

    Google Scholar 

  • Wüster M, Costa T, Aktories K, Jakobs KH (1984) Sodium regulation of opioid agonist binding is potentiated by pertussis toxin. Biochem Biophys Res Commun 123:1107–1115

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minuth, M., Jakobs, K.H. Sodium regulation of agonist and antagonist binding to β-adrenoceptors in intact and Ns-deficient membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 124–129 (1986). https://doi.org/10.1007/BF00506514

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00506514

Key words

Navigation